20 Oct 2020 12:01
20 October 2020
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Grant of SAYE options:
Dechra Pharmaceuticals PLC announces that on 19 October 2020 the following PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Global Save As You Earn Plan 2018 (the Options).
The Options have been granted with an exercise price of £28.68.
Name | Capacity | Options Granted |
Ian Page | Director | 627 |
Paul Sandland | Director | 627 |
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
a) | Name | Ian Page
| |
2. | Reason for the notification | ||
a) | Position/status | Director/PDMR
| |
b) | Initial notification/ amendment | Initial Notification | |
3. | Details of the Issuer | ||
a) | Name | Dechra Pharmaceuticals PLC | |
b) | LEI code | 213800J4UVB5OWG8VX82
| |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB0009633180 | |
b) | Nature of the transaction | Grant of 627 options under the Company's Save As You Earn Scheme | |
c) | Price(s) and volumes(s) | Price(s) £28.68 | Volume(s) 627 |
d) | Aggregated information - Aggregate volume - Price |
627 £17,982.36 | |
e) | Date of the transaction | 2020.10.19 | |
f) | Place of the transaction | Outside a trading venue | |
1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
a) | Name | Paul Sandland
| |
2. | Reason for the notification | ||
a) | Position/status | Director/PDMR
| |
b) | Initial notification/ amendment | Initial Notification | |
3. | Details of the Issuer | ||
a) | Name | Dechra Pharmaceuticals PLC | |
b) | LEI code | 213800J4UVB5OWG8VX82
| |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB0009633180 | |
b) | Nature of the transaction | Grant of 627 options under the Company's Save As You Earn Scheme | |
c) | Price(s) and volumes(s) | Price(s) £28.68 | Volume(s) 627 |
d) | Aggregated information - Aggregate volume - Price |
627 £17,982.36 | |
e) | Date of the transaction | 2020.10.19 | |
f) | Place of the transaction | Outside a trading venue | |
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.